JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB321425

Alexa Fluor® 750 Anti-Natriuretic peptides A 抗体 [EPR22089-283]

Alexa Fluor® 750 Anti-Natriuretic peptides A antibody [EPR22089-283]

Be the first to review this product! Submit a review

|

(0 Publication)

Rabbit Recombinant Monoclonal proANP antibody - conjugated to Alexa Fluor® 750.

別名を表示する

ANP, PND, NPPA, Natriuretic peptides A, Atrial natriuretic factor prohormone, Atrial natriuretic peptide prohormone, Atriopeptigen, Cardiodilatin, preproCDD-ANF, proANF, preproANP, proANP, CDD

関連する標識済み抗体及び組成の異なる製品 (6)

  • 660 APC

    APC Anti-Natriuretic peptides A antibody [EPR22089-283]

  • 578 PE

    PE Anti-Natriuretic peptides A antibody [EPR22089-283]

  • 519 Alexa Fluor® 488

    Alexa Fluor® 488 Anti-Natriuretic peptides A antibody [EPR22089-283]

  • 665 Alexa Fluor® 647

    Alexa Fluor® 647 Anti-Natriuretic peptides A antibody [EPR22089-283]

  • 617 Alexa Fluor® 594

    Alexa Fluor® 594 Anti-Natriuretic peptides A antibody [EPR22089-283]

  • 565 Alexa Fluor® 555

    Alexa Fluor® 555 Anti-Natriuretic peptides A antibody [EPR22089-283]

Key facts

宿主種

Rabbit

クローン性

Monoclonal

クローン番号

EPR22089-283

アイソタイプ

IgG

標識

Alexa Fluor® 750

励起波長/蛍光波長

Ex: 749nm, Em: 775nm

キャリアフリー

No

アプリケーション

Antibody Labelling, Target Binding Affinity

applications

免疫原

The exact immunogen used to generate this antibody is proprietary information.

特異性

This antibody is not suitable to detect ANP in H9c2 cell line.

製品の詳細

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

How are conjugated primary antibodies validated?
This conjugated primary antibody is released using a quantitative quality control method that evaluates binding affinity post-conjugation and efficiency of antibody labeling.
For suitable applications and species reactivity, please refer to the unconjugated version of this clone.

Alexa Fluor® is a registered trademark of Molecular Probes, Inc, a Thermo Fisher Scientific Company. The Alexa Fluor® dye included in this product is provided under an intellectual property license from Life Technologies Corporation. As this product contains the Alexa Fluor® dye, the purchase of this product conveys to the buyer the non-transferable right to use the purchased product and components of the product only in research conducted by the buyer (whether the buyer is an academic or for-profit entity). As this product contains the Alexa Fluor® dye the sale of this product is expressly conditioned on the buyer not using the product or its components, or any materials made using the product or its components, in any activity to generate revenue, which may include, but is not limited to use of the product or its components: in manufacturing; (ii) to provide a service, information, or data in return for payment (iii) for therapeutic, diagnostic or prophylactic purposes; or (iv) for resale, regardless of whether they are sold for use in research. For information on purchasing a license to this product for purposes other than research, contact Life Technologies Corporation, 5781 Van Allen Way, Carlsbad, CA 92008 USA or outlicensing@thermofisher.com.

出荷温度及び保存条件

製品の状態
Liquid
精製方法
Affinity purification Protein A
バッファー組成
pH: 7.4 Preservative: 0.02% Sodium azide Constituents: PBS, 30% Glycerol (glycerin, glycerine), 1% BSA
出荷温度
Blue Ice
短期保存期間
1-2 weeks
短期保存温度
+4°C
長期保存温度
-20°C
分注に関する情報
Upon delivery aliquot
保管に関する情報
Avoid freeze / thaw cycle|Store in the dark

補足情報

This supplementary information is collated from multiple sources and compiled automatically.

Natriuretic Peptides A also known as ANP ANF or NPPA are important cardiac hormones made by atrial myocytes in the heart. This peptide with a mass of around 28 amino acids plays an important role mechanically in modulating blood pressure and fluid balance. It achieves this by binding to receptors that activate cyclic GMP (cGMP) production leading to vasodilation. ANP expression is mainly found in cardiac muscle cells but also detected in other tissues under certain conditions.
Biological function summary

These peptides contribute to renal sodium excretion commonly known as natriuresis and also promote diuresis which increases urine volume. ANP functions as a singular hormone without forming part of a complex. Beyond its role in cardiovascular and renal systems ANP influences lipid metabolism and adipocyte functions which may have implications for metabolic health.

Pathways

ANP is engaged in the natriuretic peptide signaling pathway which is important for cardiovascular homeostasis. Within this pathway related proteins include B-type Natriuretic Peptide (BNP) and C-type Natriuretic Peptide (CNP) all of which share similar receptor interactions through cGMP. Additionally ANP impacts the renin-angiotensin system (RAS) a significant hormonal system regulating blood pressure and fluid balance by counteracting the actions of angiotensin II.

ANP is notably associated with heart failure where its levels can indicate disease severity and prognosis. Elevated ANP levels have also been linked to hypertension contributing to diagnostic evaluations alongside other biomarkers like BNP. Both heart failure and hypertension involve complex interactions between ANP and proteins such as angiotensin II within their pathophysiological frameworks.

製品プロトコール

For this product, it's our understanding that no specific protocols are required. You can visit:

ターゲットの情報

Atrial natriuretic peptide. Hormone that plays a key role in mediating cardio-renal homeostasis, and is involved in vascular remodeling and regulating energy metabolism (PubMed : 15741263, PubMed : 16875975, PubMed : 18835931, PubMed : 21672517, PubMed : 22307324, PubMed : 2532366, PubMed : 2825692, PubMed : 7595132, PubMed : 7720651, PubMed : 8087923, PubMed : 8653797). Acts by specifically binding and stimulating NPR1 to produce cGMP, which in turn activates effector proteins, such as PRKG1, that drive various biological responses (PubMed : 1660465, PubMed : 1672777, PubMed : 21098034, PubMed : 2162527, PubMed : 22307324, PubMed : 25401746, PubMed : 2825692, PubMed : 7720651, PubMed : 8384600, PubMed : 9893117). Regulates vasodilation, natriuresis, diuresis and aldosterone synthesis and is therefore essential for regulating blood pressure, controlling the extracellular fluid volume and maintaining the fluid-electrolyte balance (PubMed : 2532366, PubMed : 2825692, PubMed : 7595132, PubMed : 7720651, PubMed : 8087923, PubMed : 8653797). Also involved in inhibiting cardiac remodeling and cardiac hypertrophy by inducing cardiomyocyte apoptosis and attenuating the growth of cardiomyocytes and fibroblasts (PubMed : 16875975). Plays a role in female pregnancy by promoting trophoblast invasion and spiral artery remodeling in uterus, and thus prevents pregnancy-induced hypertension (By similarity). In adipose tissue, acts in various cGMP- and PKG-dependent pathways to regulate lipid metabolism and energy homeostasis (PubMed : 15741263, PubMed : 18835931, PubMed : 21672517, PubMed : 22307324). This includes up-regulating lipid metabolism and mitochondrial oxygen utilization by activating the AMP-activated protein kinase (AMPK), and increasing energy expenditure by acting via MAPK11 to promote the UCP1-dependent thermogenesis of brown adipose tissue (PubMed : 15741263, PubMed : 18835931, PubMed : 21672517, PubMed : 22307324). Binds the clearance receptor NPR3 which removes the hormone from circulation (PubMed : 1672777).. Long-acting natriuretic peptide. May have a role in cardio-renal homeostasis through regulation of natriuresis, diuresis, vasodilation, and inhibiting aldosterone synthesis (PubMed : 2532366, PubMed : 2825692, PubMed : 7595132, PubMed : 7955907, PubMed : 8087923, PubMed : 8653797). In vitro, promotes the production of cGMP and induces vasodilation (PubMed : 2825692). May promote natriuresis, at least in part, by enhancing prostaglandin E2 synthesis resulting in the inhibition of renal Na+-K+-ATPase (PubMed : 7720651). However reports on the involvement of this peptide in mammal blood volume and blood pressure homeostasis are conflicting; according to a report, in vivo it is not sufficient to activate cGMP and does not inhibit collecting duct transport nor effect diuresis and natriuresis (By similarity). Appears to bind to specific receptors that are distinct from the receptors bound by atrial natriuretic peptide and vessel dilator (PubMed : 2162527, PubMed : 2825692). Possibly enhances protein excretion in urine by decreasing proximal tubular protein reabsorption (PubMed : 11145122).. Vessel dilator. May have a role in cardio-renal homeostasis through regulation of natriuresis, diuresis, and vasodilation (PubMed : 2532366, PubMed : 7595132, PubMed : 7955907, PubMed : 8087923, PubMed : 8653797). In vitro, promotes the production of cGMP and induces vasodilation (PubMed : 2825692). May promote natriuresis, at least in part, by enhancing prostaglandin E2 synthesis resulting in the inhibition of renal Na+-K+-ATPase (PubMed : 7595132, PubMed : 7720651). However reports on the involvement of this peptide in mammal blood volume and blood pressure homeostasis are conflicting; according to a report it is not sufficient to activate cGMP and does not inhibit collecting duct transport nor effect diuresis and natriuresis (PubMed : 7831500). Appears to bind to specific receptors that are distinct from the receptors bound by the atrial natriuretic and long-acting natriuretic peptides (PubMed : 2162527, PubMed : 2825692). Possibly functions in protein excretion in urine by maintaining the integrity of the proximal tubules and enhancing protein excretion by decreasing proximal tubular protein reabsorption (PubMed : 11145122).. Kaliuretic peptide. May have a role in cardio-renal homeostasis through regulation of diuresis and inhibiting aldosterone synthesis (PubMed : 2825692, PubMed : 7595132, PubMed : 8087923). In vitro, promotes the production of cGMP and induces vasodilation (PubMed : 2825692). May promote natriuresis, at least in part, by enhancing prostaglandin E2 synthesis resulting in the inhibition of renal Na+-K+-ATPase (PubMed : 7595132, PubMed : 7720651). May have a role in potassium excretion but not sodium excretion (natriuresis) (PubMed : 8087923). Possibly enhances protein excretion in urine by decreasing proximal tubular protein reabsorption (PubMed : 11145122).. Urodilatin. Hormone produced in the kidneys that appears to be important for maintaining cardio-renal homeostasis (PubMed : 8351194, PubMed : 8779891, PubMed : 8853410). Mediates vasodilation, natriuresis and diuresis primarily in the renal system, in order to maintain the extracellular fluid volume and control the fluid-electrolyte balance (PubMed : 2528951, PubMed : 8351194, PubMed : 8779891, PubMed : 8853410). Specifically binds and stimulates cGMP production by renal transmembrane receptors, likely NPR1 (PubMed : 8384600, PubMed : 9893117). Urodilatin not ANP, may be the natriuretic peptide responsible for the regulation of sodium and water homeostasis in the kidney (PubMed : 8384600, PubMed : 8779891).. Auriculin-D. May have a role in cardio-renal homeostasis through regulation of natriuresis and vasodilation. In vivo promotes natriuresis and in vitro, vasodilates renal artery strips.. Auriculin-B. May have a role in cardio-renal homeostasis through regulation of natriuresis and vasodilation. In vivo promotes natriuresis and in vitro, vasodilates renal artery strips.. Auriculin-A. May have a role in cardio-renal homeostasis through regulation of regulation of natriuresis and vasodilation. In vivo promotes natriuresis. In vitro, vasodilates intestinal smooth muscle but not smooth muscle strips.. Atriopeptin-2. May have a role in cardio-renal homeostasis through regulation of natriuresis and vasodilation. In vivo promotes natriuresis. In vitro, selectively vasodilates intestinal and vascular smooth muscle strips.. Atriopeptin-1. May have a role in cardio-renal homeostasis through regulation of natriuresis and vasodilation. In vivo promotes natriuresis. In vitro, selectively vasodilates intestinal smooth muscle but not vascular smooth muscle strips.
See full target information NPPA

Abcam product promise

当社は、高品質な試薬を通じてお客様の研究を力強くサポートすることをお約束いたします。ご使用いただく各段階で、常にお客様をサポートできる体制を整えております。万が一、製品が期待通りに機能しない場合は、「Abcam Product Promise」による当社保証制度に基づき、安心してご利用いただけます。
保証に関する詳細については利用規約をご確認ください。

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com